Acrivon Therapeutics shares owned by Bank of America Corporation
Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by Bank of America Corporation
from 13F filings
Historical chart of Bank of America Corporation investment in Acrivon Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Acrivon Therapeutics held by Bank of America Corporation consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Acrivon Therapeutics by Bank of America Corporation
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $23k | 17k | 1.39 |
| 2024-12-31 | $187k | 31k | 6.02 |
| 2024-09-30 | $210k | 30k | 7.00 |
| 2024-06-30 | $160k | 28k | 5.80 |
| 2024-03-31 | $43k | 6.0k | 7.15 |
| 2023-12-31 | $50k | 10k | 4.92 |
| 2023-09-30 | $89k | 9.3k | 9.56 |
| 2023-06-30 | $99k | 7.6k | 12.96 |
| 2023-03-31 | $74k | 5.9k | 12.69 |
More positions owned by Bank of America Corporation
View all positions for Bank of America Corporation